Dominate Your LC-MS/MS Data, Maximize Efficiency and Bolster Regulatory Compliance with waters_connect for Quantitation 3.0

ZÁZNAM | Proběhlo Čt, 13.2.2025
Připojte se k exkluzivnímu webináři a zjistěte, jak převratný software mění pracovní postupy LC-MS/MS, přináší rychlejší a přesnější kvantifikaci a zajišťuje budoucnost vašich laboratorních operací.
Waters Corporation: Maximize LC-MS/MS Efficiency & Accuracy: A Glimpse into the Future for Regulated Pharma
Waters Corporation: Maximize LC-MS/MS Efficiency & Accuracy: A Glimpse into the Future for Regulated Pharma
A New Chapter for Regulated Labs Begins Now

Are You Ready to Revolutionize Your LC-MS/MS Workflows?

Imagine a workflow that’s not only faster and more efficient but also equipped with compliance-enabled capabilities to meet the demands of regulated environments.

Are you ready to make that change for the better?

We’re excited to invite you to a webinar that will unlock the future of LC-MS/MS data processing in regulated pharmaceutical environments.

In this session, we’ll demonstrate how waters_Connect for Quantitation 3.0 is streamlining workflows, boosting efficiency, and, enhancing data integrity, and compliance. Whether you're in a regulated or non-regulated lab, don’t miss the chance to explore how these advancements can redefine your laboratory’s potential.

What you will discover:

  • Efficiency-driven processing that reduces data review time by up to 50%
  • Built-in guidance with application-focused workflows and software
  • Data integrity tools for secure, traceable, and compliant workflows
  • Seamless connectivity for mixed-platform environments

Don’t just take our word for it - join our webinar to see waters_connect for Quantitation 3.0 in action.

Presenter: Nat Martin (Principal Consulting Product Owner, Waters Corporation)

With over nine years at Waters Corporation, Nat is the Principal Consulting Product Owner for waters_connect for Quantitation. Drawing on extensive experience as a chemist and research scientist, including a key role in the discovery of osimertinib (Tagrisso) at AstraZeneca, Nat brings deep expertise in both scientific innovation and product development.

Waters Corporation
LinkedIn Logo